Neosar Interactions
There are 409 drugs known to interact with Neosar (cyclophosphamide), along with 6 disease interactions. Of the total drug interactions, 59 are major, 321 are moderate, and 29 are minor.
- View all 409 medications that may interact with Neosar
- View Neosar disease interactions (6)
Most frequently checked interactions
View interaction reports for Neosar (cyclophosphamide) and the medicines listed below.
- acetaminophen / codeine
- acetaminophen / codeine
- acetaminophen / hydrocodone
- acetaminophen / hydrocodone
- Adriamycin (doxorubicin)
- Adriamycin (doxorubicin)
- Adrucil (fluorouracil)
- Adrucil (fluorouracil)
- aspirin
- aspirin
- Cholestyramine Light (cholestyramine)
- Cholestyramine Light (cholestyramine)
- Claritin (loratadine)
- Claritin (loratadine)
- Cosmegen (dactinomycin)
- Cosmegen (dactinomycin)
- Coumadin (warfarin)
- Coumadin (warfarin)
- Decadron (dexamethasone)
- Decadron (dexamethasone)
- Decadron Phosphate, Injectable (dexamethasone)
- Decadron Phosphate, Injectable (dexamethasone)
- Eliquis (apixaban)
- Eliquis (apixaban)
- Neulasta (pegfilgrastim)
- Neulasta (pegfilgrastim)
- Sustol (granisetron)
- Sustol (granisetron)
- Taxotere (docetaxel)
- Taxotere (docetaxel)
Neosar disease interactions
There are 6 disease interactions with Neosar (cyclophosphamide) which include:
- myelosuppression
- urinary tract obstruction
- cardiac disease/cardiotoxicity
- hepatic dysfunction
- pulmonary impairment
- renal dysfunction
Report options
More about Neosar (cyclophosphamide)
- Neosar consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.